vorinostat has been researched along with Glomerulonephritis, Lupus in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N | 1 |
| Zhao, D | 1 |
| Kirschbaum, M | 1 |
| Zhang, C | 1 |
| Lin, CL | 1 |
| Todorov, I | 1 |
| Kandeel, F | 1 |
| Forman, S | 1 |
| Zeng, D | 1 |
1 other study available for vorinostat and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen.
Topics: Aging; Animals; Apoptosis; CD3 Complex; Cell Proliferation; Chimerism; Cytokines; Dose-Response Rela | 2008 |